Investigational Site Number 1240001

Montreal H4A 3J1

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Chronic Obstructive Pulmonary Disease

Studies at this site

• Dupilumab Skin Barrier Function Study in Atopic Dermatitis — Completed
• Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed